Skin and oral lesions associated to imatinib mesylate therapy

Supportive Care in Cancer

Volumn 17, Issue 4, 2009, Pages 465-468

  Basso, Fernanda Gonçalves ^a   Boer, Camila Cominato ^a   Corrêa, Maria Elvira Pizzigatti ^a   Torrezan, Marcia ^a   Cintra, Maria Letícia ^a   De Magalhães, Marina H C Gallottini ^b   Da Silva Santos, Paulo ^b   De Souza, Cármino Antônio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Imatinib mesylate; Oral lesions; Side effects; Skin lesions

Indexed keywords

ALLOPURINOL; BECLOMETASONE; HYDROXYUREA; IMATINIB; OMEPRAZOLE; PREDNISONE;

ADULT; AGED; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DOSE RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; MALE; MOUTH LESION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RASH; SKIN DEFECT; STOMACH ULCER;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; ORAL ULCER; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 62449341505     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0536-8     Document Type: Article

References (13)

1. AM Carella F Frassoni J Melo 1997 New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia Haematologica 82 478 495
2. M Mahapatra P Mishra R Kumar 2007 Imatinib-induced Stevens-Johnson syndrome: recurrence after re-challenge with a lower dose Ann Hematol 86 537 538
3. M Breccia I Carmosino E Russo 2005 Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib Eur J Haematol 74 121 123
4. BJ Druker M Talpaz DJ Resta 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037
5. G Severino C Chillotti R De Lisa 2005 Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors Ann Pharmacother 39 162 164
6. SG O'Brien MW Deininger 2003 Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia Semin Hematol 40 Suppl 2 26 30
7. AT van Oosterom I Judson J Verweij 2001 Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study Lancet 358 1421 1423
8. M Brouard JH Saurat 2001 Cutaneous reactions to STI571 N Engl J Med 345 618 619
9. DS Lim J Muir 2002 Oral lichenoid reaction to imatinib (STI 571, Gleevec) Dermatology 205 169 171
10. JC Pascual J Matarredona J Miralles 2006 Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases Int J Dermatol 45 1471 1473
11. N Chainani-Wu F Lozada-Nur N Terrault 2004 Hepatitis C virus and lichen planus: a review Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 171 183
12. KS Cunha AC Manso AS Cardoso 2005 Prevalence of oral lichen planus in Brazilian patients with HCV infection Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 330 333
13. G Lodi M Giuliani A Majorana 2004 Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review Br J Dermatol 151 1172 1181